Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India
Abstract Macrolides are among the most widely prescribed antibiotics worldwide. However, their impact on the gut’s bacterial microbiota remains uncertain. We characterised the intestinal microbiota in 6–11 month-old infants in India who received a 3-day course of azithromycin or placebo during a ran...
Guardado en:
Autores principales: | Edward P. K. Parker, Ira Praharaj, Jacob John, Saravanakumar Puthupalayam Kaliappan, Beate Kampmann, Gagandeep Kang, Nicholas C. Grassly |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3da44427284428a948095cdcc56f312 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stopping azithromycin mass drug administration for trachoma: A systematic review.
por: Hamidah Mahmud, et al.
Publicado: (2021) -
Community Drug Distributor Knowledge, Attitudes, and Motivation Surrounding Mass Drug Administration for Soil-Transmitted Helminths in India
por: Kumudha Aruldas, et al.
Publicado: (2021) -
Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus.
por: Soumeya Hema-Ouangraoua, et al.
Publicado: (2021) -
Topical azithromycin or ofloxacin for endophthalmitis
por: Stewart ML, et al.
Publicado: (2012) -
Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study.
por: Giada De Palma, et al.
Publicado: (2012)